Page 1

APPENDIX 4E Preliminary Final Report Name of entity : Medical Developments International Limited ABN : Year ended ( ' current period ' ) 30 June 2026 14 106 340 667 Year ended ( ' previous corresponding period ' ) Results for announcement to the market The following information is provided in accordance with ASX listing rule 4.3C.2 Revenue ( net ) and other income from ordinary activities ( 1 ) Net profit after tax from ordinary activities attributable to members Net profit for the period attributable to members Basic earnings per share ( cents ) Net tangible asset backing per ordinary share ( cents ) ( 2 ) 등등등 30 June 2025 $ ' 000 9 % to 42,985 566 % 566 % to 626 to 626 Previous Current period 0.56 corresponding period 0.09 30.7 29.5 ( 1 ) Revenue ( net ) and other income from ordinary activities includes revenue of $ 42.6 million ( 2025 : $ 39.1 million ) and interest and other income of $ 0.4 million ( 2025 : $ 0.3 million ) . ( 2 ) Net tangible assets excludes goodwill and other intangible assets and deferred tax assets ( refer to notes 1.3 and 2.3 in the Full Year Consolidated Financial Report ) . For commentary on the financial performance and any other significant information needed by an investor to make an informed assessment of the results for Medical Developments International Limited please refer to the accompanying Full Year Consolidated Financial Report . Dividends No dividends were declared in respect of the current year . No dividends were declared in respect of the previous corresponding year . Annual Report Pursuant to listing rule 4.3A , please see attached Medical Developments International Limited's audited Financial Report for the year ended 30 June 2026 and associated results announcement . Tara Eaton Company Secretary Dated : 20 August 2026 Medical Developments International Ltd